Literature DB >> 26288353

IFNλ Stimulates MxA Production in Human Dermal Fibroblasts via a MAPK-Dependent STAT1-Independent Mechanism.

Adewonuola A Alase1, Yasser M El-Sherbiny2, Edward M Vital3, Desmond J Tobin4, Neil A Turner5, Miriam Wittmann6.   

Abstract

IFNλ is important for epidermal defense against viruses. It is produced by, and acts on, keratinocytes, whereas fibroblasts were previously considered to be unresponsive to this type III IFN. Herein we report findings revealing cell type-specific differences in IFNλ signaling and function in skin resident cells. In dermal fibroblasts, IFNλ induced the expression of myxovirus protein A (MxA), a potent antiviral factor, but not other IFN signature genes as it does in primary keratinocytes. In contrast to its effect on keratinocytes, IFNλ did not phosphorylate signal transducer and activator of transcription 1 in fibroblasts, but instead activated mitogen activated protein kinases (MAPK). Accordingly, inhibition of MAPK activation (p38 and p42/44) blocked the expression of MxA protein in fibroblasts but not in keratinocytes. Functionally, IFNλ inhibited proliferation in keratinocytes but not in fibroblasts. Moreover, IFNλ upregulated the expression of Tumor growth factor beta 1 (TGFβ1)-induced collagens in fibroblasts. Taken together, our findings identify primary human dermal fibroblasts as responder cells to IFNλ. Our study shows cutaneous cell type-specific IFN signaling and suggests that IFNλ, although important for epidermal antiviral competence, may also have a regulatory role in the dermal compartment balancing type I IFN-induced inhibition of tissue repair processes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26288353     DOI: 10.1038/jid.2015.317

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  51 in total

1.  IL-28, IL-29 and their class II cytokine receptor IL-28R.

Authors:  Paul Sheppard; Wayne Kindsvogel; Wenfeng Xu; Katherine Henderson; Stacy Schlutsmeyer; Theodore E Whitmore; Rolf Kuestner; Ursula Garrigues; Carl Birks; Jenny Roraback; Craig Ostrander; Dennis Dong; Jinu Shin; Scott Presnell; Brian Fox; Betty Haldeman; Emily Cooper; David Taft; Teresa Gilbert; Francis J Grant; Monica Tackett; William Krivan; Gary McKnight; Chris Clegg; Don Foster; Kevin M Klucher
Journal:  Nat Immunol       Date:  2002-12-02       Impact factor: 25.606

Review 2.  Mechanisms of mRNA translation of interferon stimulated genes.

Authors:  Sonali Joshi; Surinder Kaur; Barbara Kroczynska; Leonidas C Platanias
Journal:  Cytokine       Date:  2010-04-20       Impact factor: 3.861

3.  IL-29 and IFN-α regulate the expression of MxA, 2',5'-OAS and PKR genes in association with the activation of Raf-MEK-ERK and PI3K-AKT signal pathways in HepG2.2.15 cells.

Authors:  Yu Chai; Hai-Liang Huang; Dao-Jun Hu; Xin Luo; Qian-Shan Tao; Xiao-Ling Zhang; Sheng-Quan Zhang
Journal:  Mol Biol Rep       Date:  2010-03-23       Impact factor: 2.316

4.  Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus.

Authors:  Elisabeth Naschberger; Jörg Wenzel; Cosima C Kretz; Martin Herrmann; Michael Stürzl; Annegret Kuhn
Journal:  Exp Dermatol       Date:  2010-12-02       Impact factor: 3.960

5.  IL-29 and IFNα differ in their ability to modulate IL-12 production by TLR-activated human macrophages and exhibit differential regulation of the IFNγ receptor expression.

Authors:  Bi-Sheng Liu; Harry L A Janssen; André Boonstra
Journal:  Blood       Date:  2010-12-29       Impact factor: 22.113

Review 6.  IL-28A, IL-28B, and IL-29: promising cytokines with type I interferon-like properties.

Authors:  Katrin Witte; Ellen Witte; Robert Sabat; Kerstin Wolk
Journal:  Cytokine Growth Factor Rev       Date:  2010-07-23       Impact factor: 7.638

7.  p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons.

Authors:  K C Goh; S J Haque; B R Williams
Journal:  EMBO J       Date:  1999-10-15       Impact factor: 11.598

8.  Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression.

Authors:  Christopher R Bolen; Siyuan Ding; Michael D Robek; Steven H Kleinstein
Journal:  Hepatology       Date:  2014-02-18       Impact factor: 17.425

Review 9.  TGF-beta-induced epithelial to mesenchymal transition.

Authors:  Jian Xu; Samy Lamouille; Rik Derynck
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

Review 10.  Interferon lambda: a new sword in cancer immunotherapy.

Authors:  Ahmed Lasfar; Walid Abushahba; Murugabaskar Balan; Karine A Cohen-Solal
Journal:  Clin Dev Immunol       Date:  2011-12-06
View more
  12 in total

Review 1.  Emerging concepts of type I interferons in SLE pathogenesis and therapy.

Authors:  Antonios Psarras; Miriam Wittmann; Edward M Vital
Journal:  Nat Rev Rheumatol       Date:  2022-09-12       Impact factor: 32.286

2.  Exploring a Role for Regulatory miRNAs In Wound Healing during Ageing:Involvement of miR-200c in wound repair.

Authors:  Eerik Aunin; David Broadley; Mohammed I Ahmed; Andrei N Mardaryev; Natalia V Botchkareva
Journal:  Sci Rep       Date:  2017-06-12       Impact factor: 4.379

3.  Type I and Type III Interferons Display Different Dependency on Mitogen-Activated Protein Kinases to Mount an Antiviral State in the Human Gut.

Authors:  Kalliopi Pervolaraki; Megan L Stanifer; Stephanie Münchau; Lynnsey A Renn; Dorothee Albrecht; Stefan Kurzhals; Elena Senís; Dirk Grimm; Jutta Schröder-Braunstein; Ronald L Rabin; Steeve Boulant
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561

Review 4.  Interferon-induced guanylate-binding proteins: Guardians of host defense in health and disease.

Authors:  Kyle Tretina; Eui-Soon Park; Agnieszka Maminska; John D MacMicking
Journal:  J Exp Med       Date:  2019-02-12       Impact factor: 14.307

5.  Plucked hair follicles from patients with chronic discoid lupus erythematosus show a disease-specific molecular signature.

Authors:  Mohammad Shalbaf; Adewonuola A Alase; Anna Berekmeri; Md Yuzaiful Md Yusof; Jelena Pistolic; Mark J Goodfield; Sara Edward; Natalia V Botchkareva; Martin Stacey; Edward M Vital; Miriam Wittmann
Journal:  Lupus Sci Med       Date:  2019-07-14

6.  TRIM26 Facilitates HSV-2 Infection by Downregulating Antiviral Responses through the IRF3 Pathway.

Authors:  Tushar Dhawan; Muhammad Atif Zahoor; Nishant Heryani; Samuel Tekeste Workenhe; Aisha Nazli; Charu Kaushic
Journal:  Viruses       Date:  2021-01-06       Impact factor: 5.048

Review 7.  Interferons: Tug of War Between Bacteria and Their Host.

Authors:  Noémie Alphonse; Ruth E Dickenson; Charlotte Odendall
Journal:  Front Cell Infect Microbiol       Date:  2021-03-10       Impact factor: 5.293

Review 8.  Interferon lambda in inflammation and autoimmune rheumatic diseases.

Authors:  Rishi R Goel; Sergei V Kotenko; Mariana J Kaplan
Journal:  Nat Rev Rheumatol       Date:  2021-04-27       Impact factor: 20.543

9.  Differential induction of interferon stimulated genes between type I and type III interferons is independent of interferon receptor abundance.

Authors:  Kalliopi Pervolaraki; Soheil Rastgou Talemi; Dorothee Albrecht; Felix Bormann; Connor Bamford; Juan L Mendoza; K Christopher Garcia; John McLauchlan; Thomas Höfer; Megan L Stanifer; Steeve Boulant
Journal:  PLoS Pathog       Date:  2018-11-28       Impact factor: 6.823

Review 10.  Non-invasive Approaches for the Diagnosis of Autoimmune/Autoinflammatory Skin Diseases-A Focus on Psoriasis and Lupus erythematosus.

Authors:  Anna Berekméri; Ana Tiganescu; Adewonuola A Alase; Edward Vital; Martin Stacey; Miriam Wittmann
Journal:  Front Immunol       Date:  2019-08-21       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.